Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | TYR | P14679 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.49 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17077436 | 1.00 | ALPI (0.53) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL2804085 | 0.98 | TYR (0.55) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL14965068 | 0.98 | TYR (0.55) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL7780483 | 0.98 | TYR (0.55) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL21585495 | 0.98 | TYR (0.55) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL22654085 | 0.98 | TYR (0.55) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL7780482 | 0.98 | TYR (0.55) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL11220049 | 0.98 | TYR (0.55) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL2214344 | 0.98 | TYR (0.55) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL22654084 | 0.98 | TYR (0.55) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110520195-B | Novel nucleoside phosphonate prodrugs | 勒芬天主教大学 | 2023-01-17 | — | — | CN | claimed |
| CN-102695521-B | Plant extract, composition containing said extract, extraction method and use thereof | 博仲盛景医药技术（北京）有限公司 | 2016-06-08 | — | — | CN | claimed |
| CN-104606086-A | Plant extract, composite containing extract, and extraction method and application of extract | BOTAN CENTURY MEDICAL TECHNOLOGY BEIJING CO LTD | 2015-05-13 | — | — | CN | claimed |
| CN-102223874-B | Cosmetic compositions | PROCTER & GAMBLE | 2014-12-31 | — | — | CN | claimed |
| CN-103550135-A | Whitening composition and cosmetic | GUANGZHOU RIDGEPOLE DAILY CHEMICALS CO LTD | 2014-02-05 | — | — | CN | claimed |
| CN-103298449-A | Cosmetic compositions and methods based on cyclohexa-1, 2,3,4,5, 6-hexaol and N-acyl amino acid compounds for inhibiting or reducing trypsin activity | PROCTER & GAMBLE | 2013-09-11 | — | — | CN | claimed |
| CN-102018766-B | Plant extractive, extraction method and application thereof as well as composite comprising same | BEIJING BOZHONGSHENGJING MEDICINE TECHNOLOGY CO LTD | 2013-03-06 | — | — | CN | claimed |
| CN-102695521-A | Plant extract, composition containing said extract, extraction method and use thereof | BOTAN CENTURY BEIJING CO LTD | 2012-09-26 | — | — | CN | claimed |
| EP-2103601-B1 | PROCESS FOR PRODUCTION OF PHENYLALANINE DERIVATIVES HAVING QUINAZOLINEDIONE SKELETONS AND INTERMEDIATES FOR THE PRODUCTION | AJINOMOTO KK (JP) | 2012-03-14 | — | — | EP | claimed |
| US-20110313154-A1 | METHOD FOR PREPARING PHENYLALANINE DERIVATIVES HAVING QUINAZOLINE-DIONE SKELETON AND INTERMEDIATES FOR USE IN THE PREPARATION OF THE DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2011-12-22 | — | — | US | claimed |
| CN-102223874-A | Cosmetic compositions | PROCTER & GAMBLE | 2011-10-19 | — | — | CN | claimed |
| CN-102018766-A | Plant extractive, extraction method and application thereof as well as composite comprising same | BEIJING BOZHONGSHENGJING MEDICINE TECHNOLOGY CO LTD | 2011-04-20 | — | — | CN | claimed |
| US-20090318688-A1 | METHOD FOR PREPARING PHENYLALANINE DERIVATIVES HAVING QUINAZOLINE-DIONE SKELETON AND INTERMEDIATES FOR USE IN THE PREPARATION OF DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2009-12-24 | — | — | US | claimed |
| CN-101578086-A | cosmetic composition | PROCTER & GAMBLE (US) | 2009-11-11 | — | — | CN | claimed |
| EP-2103601-A1 | PROCESS FOR PRODUCTION OF PHENYLALANINE DERIVATIVES HAVING QUINAZOLINEDIONE SKELETONS AND INTERMEDIATES FOR THE PRODUCTION | Ajinomoto Co., Inc. (JP) | 2009-09-23 | — | — | EP | claimed |
| CN-101321557-A | Personal care compositions comprising dehydroacetate salts | PROCTER & GAMBLE (US) | 2008-12-10 | — | — | CN | claimed |
| WO-2024084096-A1 | PHOTOSENSITIVE DIAZIRINE-CONJUGATED PHOSPHOLIPIDS AND USES THEREOF | Universite de Bordeaux (FR) | 2024-04-25 | — | — | WO | disclosed |
| EP-4356930-A1 | PHOTOSENSITIVE DIAZIRINE-CONJUGATED PHOSPHOLIPIDS AND USES THEREOF | UNIVERSITE DE BORDEAUX (FR) | 2024-04-24 | — | — | EP | disclosed |
| CN-1124006-A | Cholesterol lowering drink mix compositions | PROCTER & GAMBLE (US) | 1996-06-05 | — | — | CN | disclosed |
| CN-1042289-A | Improve the method for chewing gum to reduce alkitol bulding agent spots using gum rework material | WRIGLEY W M JUN CO (US) | 1990-05-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318688-A1 | METHOD FOR PREPARING PHENYLALANINE DERIVATIVES HAVING QUINAZOLINE-DIONE SKELETON AND INTERMEDIATES FOR USE IN THE PREPARATION OF DERIVATIVES | PAH, DDC, AADAT | ALPI 1223/4885PKM 545/4885PTGS1 3351/4885 |
| US-20110313154-A1 | METHOD FOR PREPARING PHENYLALANINE DERIVATIVES HAVING QUINAZOLINE-DIONE SKELETON AND INTERMEDIATES FOR USE IN THE PREPARATION OF THE DERIVATIVES | PAH, DDC, ASNS | ALPI 1254/4885PKM 637/4885PTGS1 3543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.